Core Laboratories Revenue

CLB
 Stock
  

USD 21.97  0.47  2.19%   

Core Laboratories NV fundamentals help investors to digest information that contributes to Core Laboratories' financial success or failures. It also enables traders to predict the movement of Core Laboratories Stock. The fundamental analysis module provides a way to measure Core Laboratories' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Core Laboratories stock.
This module does not cover all equities due to inconsistencies in global equity categorizations. Continue to Equity Screeners to view more equity screening tools.
  
The current year Deferred Revenue is expected to grow to about 9.7 M. The current year Cost of Revenue is expected to grow to about 412.3 M.

Core Laboratories Revenue Analysis

Core Laboratories' Revenue is income that a firm generates from business activities such us rendering services or selling goods to customers. It is a crucial part of a business and an essential item when evaluating a company's financial statements. Revenues from a firm's primary business operations can be reported on the income statement as sales revenue, net sales, or simply sales, depending on the industry in which a given company operates.

Core Laboratories Revenues

569.4 Million

Revenue 
 = 
Money Received 
Discounts and Returns 
More About Revenue | All Equity Analysis

Current Core Laboratories Revenue

    
  470.25 M  
Most of Core Laboratories' fundamental indicators, such as Revenue, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Core Laboratories NV is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.

Core Laboratories Revenue Historical Pattern

Today, most investors in Core Laboratories Stock are looking for potential investment opportunities by analyzing not only static indicators but also various Core Laboratories' growth ratios. Consistent increases or drops in fundamental ratios usually indicate a possible pattern that can be successfully translated into profits. However, when comparing two companies, knowing each company's revenue growth rates may not be enough to decide which company is a better investment. That's why investors frequently use a static breakdown of Core Laboratories revenue as a starting point in their analysis.
   Core Laboratories Revenue   
Share
       Timeline  
Revenue is typically recorded when cash or cash equivalents are exchanged for services or goods and can include product or services discounts, promotions, as well as early payments on invoices or services rendered in advance.
Compare to competition

Core Laboratories Deferred Revenue

Deferred Revenue

9.66 Million

Core Laboratories Deferred Revenue is projected to decrease significantly based on the last few years of reporting. The past year's Deferred Revenue was at 7.76 Million
Based on the latest financial disclosure, Core Laboratories NV reported 470.25 M of revenue. This is 99.04% lower than that of the Energy Equipment & Services sector and 85.15% lower than that of the Energy industry. The revenue for all United States stocks is 95.02% higher than that of the company.

Core Laboratories Revenue Peer Comparison

Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Core Laboratories' direct or indirect competition against its Revenue to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Core Laboratories could also be used in its relative valuation, which is a method of valuing Core Laboratories by comparing valuation metrics of similar companies.
Core Laboratories is currently under evaluation in revenue category among related companies.

Core Laboratories Current Valuation Drivers

We derive many important indicators used in calculating different scores of Core Laboratories from analyzing Core Laboratories' financial statements. These drivers represent accounts that assess Core Laboratories' ability to generate profits relative to its revenue, operating costs, and shareholders' equity. Below are some of Core Laboratories' important valuation drivers and their relationship over time.
201720182019202020212022 (projected)
Average Assets582.93 M629.33 M783.91 M605.11 M587.5 M674.84 M
Earnings Before Interest Taxes and Depreciation Amortization EBITDA136.63 M141.39 M126.99 M(56.5 M)63.29 M64.95 M
Earnings Before Interest Taxes and Depreciation Amortization USD136.63 M141.39 M126.99 M(56.5 M)63.29 M64.95 M
Earnings before Tax101.37 M104.97 M89.69 M(91.74 M)35.62 M36.56 M
Average Equity147.78 M153.9 M184.88 M66.74 M151.23 M138.05 M
Enterprise Value5.06 B2.92 B2.03 B1.5 B1.27 B1.3 B
Free Cash Flow105.82 M89.78 M67.97 M47.22 M23.4 M24.02 M
Invested Capital508.38 M590.47 M802.9 M683.97 M615.05 M677.71 M
Invested Capital Average507.54 M568.48 M791.85 M711.4 M630.07 M676.48 M
Market Capitalization4.84 B2.64 B1.67 B1.18 B1.03 B1.06 B
Tangible Asset Value396.37 M416.36 M543.8 M460.55 M473.27 M512.29 M
Working Capital106.85 M128.43 M109.64 M76.1 M98.27 M103.68 M

Core Laboratories Institutional Holders

Institutional Holdings refers to the ownership stake in Core Laboratories that is held by large financial organizations, pension funds or endowments. Institutions may purchase large blocks of Core Laboratories' outstanding shares and can exert considerable influence upon its management. Institutional holders may also work to push the share price higher once they own the stock. Extensive social media coverage, TV shows, articles in high-profile magazines, and presentations at investor conferences help move the stock higher, increasing Core Laboratories' value.
Security TypeSharesValue
Zurcher Kantonalbank Zurich CantonalbankCommon Shares6.5 K88 K
Zurcher Kantonalbank Zurich CantonalbankCommon Shares6.5 K129 K
Zurcher Kantonalbank Zurich CantonalbankCommon Shares6.5 K206 K
Zurcher Kantonalbank Zurich CantonalbankCommon Shares6.5 K145 K
Zurcher Kantonalbank Zurich CantonalbankCommon Shares4.4 K122 K
Zurcher Kantonalbank Zurich CantonalbankCommon Shares4.4 K172 K
Zurcher Kantonalbank Zurich CantonalbankCommon Shares4.4 K127 K

Core Laboratories Fundamentals

About Core Laboratories Fundamental Analysis

The Macroaxis Fundamental Analysis modules help investors analyze Core Laboratories NV's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Core Laboratories using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Core Laboratories NV based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Last ReportedProjected for 2022
Deferred Revenue7.8 M9.7 M
Cost of Revenue367.9 M412.3 M
Revenues470.3 M569.4 M

Core Laboratories Investors Sentiment

The influence of Core Laboratories' investor sentiment on the probability of its price appreciation or decline could be a good factor in your decision-making process regarding taking a position in Core Laboratories. The overall investor sentiment generally increases the direction of a stock movement in a one-year investment horizon. However, the impact of investor sentiment on the entire stock markets does not have a solid backing from leading economists and market statisticians.
Investor biases related to Core Laboratories' public news can be used to forecast risks associated with investment in Core Laboratories. The trend in average sentiment can be used to explain how an investor holding Core Laboratories can time the market purely based on public headlines and social activities around Core Laboratories NV. Please note that most equiteis that are difficult to arbitrage are affected by market sentiment the most.
Core Laboratories' market sentiment shows the aggregated news analyzed to detect positive and negative mentions from the text and comments. The data is normalized to provide daily scores for Core Laboratories' and other traded tickers. The bigger the bubble, the more accurate is the estimated score. Higher bars for a given day show more participation in the average Core Laboratories' news discussions. The higher the estimated score, the more favorable is the investor's outlook on Core Laboratories.
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Core Laboratories in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Core Laboratories' short interest history, or implied volatility extrapolated from Core Laboratories options trading.

Pair Trading with Core Laboratories

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Core Laboratories position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Core Laboratories will appreciate offsetting losses from the drop in the long position's value.

Moving together with Core Laboratories

+0.9XPROExpro Group Holdings Upward RallyPairCorr
+0.94APAAPA Corporation Potential GrowthPairCorr
+0.82ARCHArch Resources Normal TradingPairCorr
The ability to find closely correlated positions to Core Laboratories could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Core Laboratories when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Core Laboratories - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Core Laboratories NV to buy it.
The correlation of Core Laboratories is a statistical measure of how it moves in relation to other equities. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Core Laboratories moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Core Laboratories moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Core Laboratories can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching
Continue to Core Laboratories Piotroski F Score and Core Laboratories Altman Z Score analysis. You can also try Probability Of Bankruptcy module to get analysis of equity chance of financial distress in the next 2 years.

Complementary Tools for analysis

When running Core Laboratories price analysis, check to measure Core Laboratories' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Core Laboratories is operating at the current time. Most of Core Laboratories' value examination focuses on studying past and present price action to predict the probability of Core Laboratories' future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Core Laboratories' price. Additionally, you may evaluate how the addition of Core Laboratories to your portfolios can decrease your overall portfolio volatility.
Crypto Correlations
Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins
Go
Price Exposure Probability
Analyze equity upside and downside potential for a given time horizon across multiple markets
Go
CEO Directory
Screen CEOs from public companies around the world
Go
Companies Directory
Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals
Go
Options Analysis
Analyze and evaluate options and option chains as a potential hedge for your portfolios
Go
Portfolio Diagnostics
Use generated alerts and portfolio events aggregator to diagnose current holdings
Go
Portfolio Backtesting
Avoid under-diversification and over-optimization by backtesting your portfolios
Go
Fund Screener
Find actively-traded funds from around the world traded on over 30 global exchanges
Go
Pair Correlation
Compare performance and examine fundamental relationship between any two equity instruments
Go
Commodity Channel Index
Use Commodity Channel Index to analyze current equity momentum
Go
Probability Of Bankruptcy
Get analysis of equity chance of financial distress in the next 2 years
Go
Is Core Laboratories' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Core Laboratories. If investors know Core Laboratories will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Core Laboratories listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth YOY
7.47
Market Capitalization
B
Quarterly Revenue Growth YOY
0.068
Return On Assets
0.044
Return On Equity
0.0915
The market value of Core Laboratories is measured differently than its book value, which is the value of Core Laboratories that is recorded on the company's balance sheet. Investors also form their own opinion of Core Laboratories' value that differs from its market value or its book value, called intrinsic value, which is Core Laboratories' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Core Laboratories' market value can be influenced by many factors that don't directly affect Core Laboratories' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Core Laboratories' value and its price as these two are different measures arrived at by different means. Investors typically determine Core Laboratories value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Core Laboratories' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.